Prism Medico discloses no new share encumbrances by promoters during FY2026 under SEBI Takeover Regulations.
Filing confirms promoters maintained existing share pledges without additional encumbrances throughout financial year.
Disclosure submitted to BSE and MSEI as mandatory regulatory compliance under Regulation 31(4).